DIABETIC NEPHROPATHIES
Clinical trials for DIABETIC NEPHROPATHIES explained in plain language.
Never miss a new study
Get alerted when new DIABETIC NEPHROPATHIES trials appear
Sign up with your email to follow new studies for DIABETIC NEPHROPATHIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to protect failing kidneys
Disease control Recruiting nowThis study is testing an experimental drug called WAL0921 in people with specific kidney diseases that cause protein to leak into the urine. Participants will receive either the drug or a placebo via an IV infusion every two weeks for about three months. The main goals are to see…
Matched conditions: DIABETIC NEPHROPATHIES
Phase: PHASE2 • Sponsor: Walden Biosciences • Aim: Disease control
Last updated Apr 02, 2026 02:11 UTC
-
New peptide solution aims to halt kidney damage in millions
Disease control Recruiting nowThis study is testing whether a new oral solution called ACE Reno can help protect kidney function in people with various types of kidney disease. About 300 adults with kidney problems from diabetes, high blood pressure, autoimmune conditions, or other causes will take the soluti…
Matched conditions: DIABETIC NEPHROPATHIES
Phase: PHASE4 • Sponsor: Ace Cells Lab Limited • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Asthma drug shows promise in slowing diabetic kidney damage
Disease control Recruiting nowThis study is testing whether adding formoterol, a medication commonly used for asthma, to standard care can help people with diabetic kidney disease. About 120 participants will be randomly assigned to receive either formoterol plus their usual care or just their usual care alon…
Matched conditions: DIABETIC NEPHROPATHIES
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Breakthrough drug trial aims to save kidneys in type 1 diabetes
Disease control Recruiting nowThis study is testing whether a pill called sotagliflozin can slow down kidney damage in 150 people who have both type 1 diabetes and moderate to severe kidney disease. Participants will take either the real pill or a placebo (inactive pill) daily for three years, while following…
Matched conditions: DIABETIC NEPHROPATHIES
Phase: PHASE3 • Sponsor: Alessandro Doria • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Scientists hunt for clues in diabetic kidneys to stop rapid failure
Knowledge-focused Recruiting nowThis study aims to understand why some people with diabetes lose kidney function very quickly while others decline more slowly. Researchers will collect kidney tissue, blood, and urine from 400 diabetic adults who are already scheduled for a medically necessary kidney biopsy. By …
Matched conditions: DIABETIC NEPHROPATHIES
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC
-
Scientists take deep dive into diabetic kidneys to find future treatments
Knowledge-focused Recruiting nowThis study aims to learn more about kidney disease in people with Type 2 diabetes. Researchers will collect kidney tissue and other samples from 300 participants to look for patterns that can improve diagnosis and predict how the disease might progress. The goal is to gather know…
Matched conditions: DIABETIC NEPHROPATHIES
Sponsor: Herlev Hospital • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC
-
Scientists search for clues in kidney tissue to understand diabetes drug effects
Knowledge-focused Recruiting nowThis study aims to understand how certain diabetes medicines (called SGLT2 inhibitors) affect the kidneys. Researchers will examine stored kidney tissue samples from 200 adults with diabetic kidney disease who are already having a biopsy or surgery as part of their regular care. …
Matched conditions: DIABETIC NEPHROPATHIES
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:16 UTC